Our Vision In Action

Our powerful computational platform is accelerating the discovery and development of new medicines for patients with unmet medical needs.

To fully leverage our platform, we have built a talented, cross-functional team of drug discovery and translational scientists – backed by virtually unlimited computing resources – to advance our pipeline of internal and partnered therapeutics.

In addition to launching multiple wholly-owned discovery programs, we have teamed up with venture capitalists, leading academics, and biopharma companies around the globe to establish research partnerships and co-found biotech startups. The results speak for themselves: Two novel drugs have been approved by the FDA, two are in clinical studies, and more than two dozen programs are progressing through preclinical discovery across a broad array of therapeutic indications.